 Jay Hesselberth
Concepts (398)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 17 | 2025 | 557 | 2.690 |
Why?
| | Sequence Analysis, RNA | 10 | 2025 | 452 | 2.140 |
Why?
| | Saccharomyces cerevisiae Proteins | 9 | 2023 | 405 | 1.850 |
Why?
| | Single-Cell Analysis | 10 | 2025 | 313 | 1.730 |
Why?
| | RNA Splicing | 4 | 2019 | 269 | 1.490 |
Why?
| | DNA Repair | 4 | 2020 | 231 | 1.280 |
Why?
| | RNA, Messenger | 16 | 2025 | 2833 | 1.260 |
Why?
| | RNA | 7 | 2023 | 921 | 1.210 |
Why?
| | RNA, Transfer | 3 | 2025 | 138 | 1.200 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2019 | 41 | 1.170 |
Why?
| | RNA Stability | 5 | 2025 | 117 | 1.030 |
Why?
| | Aminoacylation | 1 | 2025 | 14 | 0.960 |
Why?
| | High-Throughput Nucleotide Sequencing | 9 | 2020 | 539 | 0.950 |
Why?
| | Repressor Proteins | 2 | 2019 | 427 | 0.910 |
Why?
| | Unfolded Protein Response | 4 | 2019 | 59 | 0.890 |
Why?
| | Sequence Analysis, DNA | 5 | 2020 | 812 | 0.860 |
Why?
| | Introns | 5 | 2017 | 258 | 0.710 |
Why?
| | RNA Ligase (ATP) | 3 | 2017 | 6 | 0.710 |
Why?
| | Gene Expression Regulation, Fungal | 3 | 2019 | 72 | 0.690 |
Why?
| | Endoribonucleases | 3 | 2015 | 81 | 0.660 |
Why?
| | RNA Cleavage | 2 | 2015 | 10 | 0.580 |
Why?
| | Phosphorylation | 1 | 2023 | 1759 | 0.580 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 45 | 0.560 |
Why?
| | DNA | 3 | 2021 | 1459 | 0.560 |
Why?
| | Protein Interaction Mapping | 3 | 2010 | 109 | 0.550 |
Why?
| | Cell Cycle Proteins | 2 | 2017 | 617 | 0.520 |
Why?
| | RNA Precursors | 4 | 2014 | 154 | 0.520 |
Why?
| | Gene Expression | 3 | 2020 | 1502 | 0.500 |
Why?
| | Base Sequence | 11 | 2015 | 2181 | 0.480 |
Why?
| | Transcriptome | 4 | 2022 | 971 | 0.470 |
Why?
| | RNA Nucleotidyltransferases | 2 | 2014 | 21 | 0.460 |
Why?
| | Pyrimidine Dimers | 1 | 2014 | 6 | 0.450 |
Why?
| | DNA Repair Enzymes | 1 | 2014 | 28 | 0.440 |
Why?
| | RNA, Catalytic | 5 | 2004 | 187 | 0.430 |
Why?
| | MicroRNAs | 4 | 2016 | 692 | 0.360 |
Why?
| | Alternative Splicing | 1 | 2013 | 229 | 0.360 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 181 | 0.350 |
Why?
| | Lymph Nodes | 3 | 2024 | 491 | 0.340 |
Why?
| | Saccharomyces | 1 | 2010 | 8 | 0.340 |
Why?
| | Chimera | 1 | 2010 | 58 | 0.330 |
Why?
| | Molecular Sequence Data | 12 | 2015 | 2900 | 0.320 |
Why?
| | B-Lymphocytes | 2 | 2025 | 847 | 0.310 |
Why?
| | DNA Footprinting | 1 | 2009 | 33 | 0.310 |
Why?
| | Peptides | 2 | 2025 | 985 | 0.310 |
Why?
| | Spliceosomes | 3 | 2014 | 48 | 0.310 |
Why?
| | Nucleosomes | 1 | 2010 | 155 | 0.290 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2025 | 900 | 0.280 |
Why?
| | Biosensing Techniques | 4 | 2006 | 129 | 0.280 |
Why?
| | Binding Sites | 6 | 2018 | 1303 | 0.270 |
Why?
| | Uracil | 2 | 2018 | 31 | 0.270 |
Why?
| | DNA Replication | 3 | 2017 | 238 | 0.270 |
Why?
| | Software | 4 | 2021 | 665 | 0.270 |
Why?
| | Models, Genetic | 4 | 2010 | 600 | 0.250 |
Why?
| | Oligonucleotides | 3 | 2004 | 148 | 0.250 |
Why?
| | Protein Array Analysis | 1 | 2006 | 57 | 0.250 |
Why?
| | Hibernation | 2 | 2018 | 75 | 0.250 |
Why?
| | Ligases | 2 | 2003 | 32 | 0.250 |
Why?
| | Polyadenylation | 2 | 2017 | 42 | 0.240 |
Why?
| | Computational Biology | 4 | 2021 | 644 | 0.240 |
Why?
| | Chikungunya Fever | 2 | 2024 | 79 | 0.240 |
Why?
| | Immunologic Memory | 2 | 2025 | 353 | 0.240 |
Why?
| | Blotting, Northern | 1 | 2025 | 201 | 0.240 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1250 | 0.240 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2025 | 16 | 0.230 |
Why?
| | Codon, Nonsense | 1 | 2025 | 44 | 0.230 |
Why?
| | Genome, Fungal | 3 | 2017 | 40 | 0.230 |
Why?
| | Amino Acid Sequence | 4 | 2025 | 2139 | 0.230 |
Why?
| | Cell Differentiation | 4 | 2023 | 1991 | 0.230 |
Why?
| | Nucleotides | 1 | 2025 | 125 | 0.230 |
Why?
| | Exons | 2 | 2017 | 355 | 0.220 |
Why?
| | Endothelial Cells | 5 | 2024 | 785 | 0.220 |
Why?
| | Transcription Factors | 3 | 2023 | 1719 | 0.210 |
Why?
| | Protein Binding | 7 | 2020 | 2224 | 0.210 |
Why?
| | RNA, Small Nuclear | 3 | 2014 | 37 | 0.210 |
Why?
| | Gene Library | 3 | 2019 | 118 | 0.210 |
Why?
| | Mutation | 7 | 2020 | 3958 | 0.210 |
Why?
| | Genetic Techniques | 3 | 2015 | 64 | 0.200 |
Why?
| | Gene Expression Profiling | 6 | 2021 | 1774 | 0.200 |
Why?
| | RNA, Viral | 3 | 2021 | 656 | 0.200 |
Why?
| | Yeasts | 2 | 2018 | 53 | 0.200 |
Why?
| | Signal Transduction | 5 | 2020 | 5079 | 0.200 |
Why?
| | Viral Proteins | 1 | 2025 | 342 | 0.200 |
Why?
| | Chikungunya virus | 1 | 2024 | 80 | 0.200 |
Why?
| | Animals | 20 | 2025 | 36940 | 0.190 |
Why?
| | Stress, Physiological | 1 | 2025 | 443 | 0.190 |
Why?
| | Escherichia coli | 2 | 2018 | 815 | 0.190 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 36 | 0.180 |
Why?
| | Haploinsufficiency | 1 | 2021 | 56 | 0.180 |
Why?
| | Mice | 11 | 2025 | 17787 | 0.180 |
Why?
| | Alphavirus Infections | 1 | 2021 | 44 | 0.180 |
Why?
| | Replication Origin | 2 | 2017 | 19 | 0.180 |
Why?
| | Immunoprecipitation | 3 | 2016 | 155 | 0.180 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1142 | 0.170 |
Why?
| | Gene Editing | 1 | 2021 | 80 | 0.170 |
Why?
| | Murine hepatitis virus | 1 | 2020 | 16 | 0.170 |
Why?
| | Viremia | 1 | 2021 | 138 | 0.170 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2020 | 7 | 0.170 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 5757 | 0.170 |
Why?
| | Ricin | 1 | 2000 | 8 | 0.170 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 216 | 0.170 |
Why?
| | Sensitivity and Specificity | 4 | 2016 | 1946 | 0.160 |
Why?
| | Sequence Alignment | 2 | 2014 | 343 | 0.160 |
Why?
| | Machine Learning | 1 | 2025 | 493 | 0.160 |
Why?
| | Viral Nonstructural Proteins | 1 | 2020 | 65 | 0.160 |
Why?
| | rac GTP-Binding Proteins | 1 | 2020 | 32 | 0.160 |
Why?
| | Cerebellar Neoplasms | 1 | 2022 | 152 | 0.160 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2020 | 30 | 0.160 |
Why?
| | Cluster Analysis | 2 | 2019 | 499 | 0.160 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 80 | 0.160 |
Why?
| | Medulloblastoma | 1 | 2022 | 193 | 0.160 |
Why?
| | Extracellular Fluid | 1 | 2019 | 31 | 0.160 |
Why?
| | Genetic Therapy | 1 | 2021 | 297 | 0.160 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 60 | 0.160 |
Why?
| | Cell Line | 4 | 2020 | 2847 | 0.160 |
Why?
| | Integrins | 1 | 2020 | 95 | 0.160 |
Why?
| | Antigens | 1 | 2021 | 357 | 0.150 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 70 | 0.150 |
Why?
| | DNA, Single-Stranded | 1 | 2000 | 118 | 0.150 |
Why?
| | DNA, Complementary | 1 | 2019 | 272 | 0.150 |
Why?
| | Hematopoiesis | 1 | 2020 | 192 | 0.150 |
Why?
| | RNA Editing | 1 | 2018 | 24 | 0.150 |
Why?
| | Exoribonucleases | 1 | 2019 | 49 | 0.150 |
Why?
| | Thymocytes | 1 | 2018 | 36 | 0.150 |
Why?
| | Ependymoma | 1 | 2020 | 165 | 0.150 |
Why?
| | Tunicamycin | 1 | 2017 | 12 | 0.140 |
Why?
| | Bleomycin | 1 | 2019 | 248 | 0.140 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 114 | 0.140 |
Why?
| | Chromatids | 1 | 2017 | 9 | 0.140 |
Why?
| | Substrate Specificity | 2 | 2017 | 372 | 0.140 |
Why?
| | Lymphocytes | 1 | 2020 | 397 | 0.140 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2020 | 136 | 0.140 |
Why?
| | Cells, Cultured | 7 | 2021 | 4193 | 0.140 |
Why?
| | Natural Killer T-Cells | 1 | 2018 | 67 | 0.140 |
Why?
| | Azacitidine | 1 | 2018 | 140 | 0.140 |
Why?
| | Precision Medicine | 1 | 2021 | 429 | 0.140 |
Why?
| | Epilepsy | 1 | 2021 | 333 | 0.140 |
Why?
| | Meiosis | 1 | 2017 | 82 | 0.140 |
Why?
| | Superoxide Dismutase | 1 | 2019 | 346 | 0.130 |
Why?
| | Autoantibodies | 1 | 2025 | 1496 | 0.130 |
Why?
| | Hepatitis C, Chronic | 1 | 2019 | 164 | 0.130 |
Why?
| | Regeneration | 1 | 2019 | 197 | 0.130 |
Why?
| | Ligands | 4 | 2006 | 664 | 0.130 |
Why?
| | RNA-Binding Proteins | 2 | 2016 | 422 | 0.130 |
Why?
| | Mutagenesis | 1 | 2017 | 179 | 0.130 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 227 | 0.130 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2007 | 767 | 0.130 |
Why?
| | DNA, Mitochondrial | 2 | 2015 | 200 | 0.130 |
Why?
| | Humans | 28 | 2025 | 137585 | 0.130 |
Why?
| | Mammals | 1 | 2018 | 283 | 0.130 |
Why?
| | Recombination, Genetic | 1 | 2017 | 204 | 0.130 |
Why?
| | Host-Pathogen Interactions | 2 | 2021 | 364 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 391 | 0.130 |
Why?
| | Virus Integration | 1 | 2016 | 71 | 0.130 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 500 | 0.130 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 480 | 0.130 |
Why?
| | Lung Injury | 1 | 2019 | 219 | 0.120 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 558 | 0.120 |
Why?
| | Macrophages | 3 | 2021 | 1547 | 0.120 |
Why?
| | RNA, Fungal | 2 | 2014 | 72 | 0.120 |
Why?
| | Phenotype | 3 | 2020 | 3196 | 0.120 |
Why?
| | T-Lymphocyte Subsets | 1 | 2018 | 417 | 0.120 |
Why?
| | Nucleic Acid Conformation | 3 | 2013 | 728 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2019 | 279 | 0.120 |
Why?
| | Carcinogenesis | 1 | 2017 | 217 | 0.120 |
Why?
| | Gene Expression Regulation | 2 | 2018 | 2607 | 0.120 |
Why?
| | Artifacts | 1 | 2016 | 129 | 0.120 |
Why?
| | Extracellular Matrix | 1 | 2019 | 528 | 0.120 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 30 | 0.120 |
Why?
| | Temperature | 1 | 2018 | 679 | 0.120 |
Why?
| | Mitochondrial Proteins | 1 | 2017 | 257 | 0.120 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.120 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.120 |
Why?
| | DNA Damage | 1 | 2018 | 420 | 0.120 |
Why?
| | Ribonucleotides | 1 | 2015 | 26 | 0.120 |
Why?
| | Ultraviolet Rays | 1 | 2018 | 396 | 0.120 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2015 | 19 | 0.110 |
Why?
| | Brain | 2 | 2018 | 2668 | 0.110 |
Why?
| | Sulfonamides | 1 | 2018 | 513 | 0.110 |
Why?
| | Thermogenesis | 1 | 2015 | 44 | 0.110 |
Why?
| | Genomics | 1 | 2020 | 795 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 158 | 0.110 |
Why?
| | Catalysis | 2 | 2014 | 307 | 0.110 |
Why?
| | Adipose Tissue, Brown | 1 | 2015 | 53 | 0.110 |
Why?
| | Protein Biosynthesis | 3 | 2002 | 433 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2018 | 399 | 0.110 |
Why?
| | DNA, Viral | 1 | 2016 | 364 | 0.110 |
Why?
| | Ribonuclease, Pancreatic | 1 | 2014 | 12 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 718 | 0.110 |
Why?
| | Influenza A virus | 1 | 2014 | 107 | 0.110 |
Why?
| | RNA, Small Nucleolar | 1 | 2013 | 9 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2553 | 0.100 |
Why?
| | Breast Neoplasms | 2 | 2017 | 2253 | 0.100 |
Why?
| | Drosophila Proteins | 1 | 2015 | 204 | 0.100 |
Why?
| | Drosophila melanogaster | 1 | 2015 | 233 | 0.100 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 2013 | 11 | 0.100 |
Why?
| | Escherichia coli Proteins | 1 | 2015 | 200 | 0.100 |
Why?
| | Nucleic Acids | 2 | 2006 | 71 | 0.100 |
Why?
| | Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2013 | 11 | 0.100 |
Why?
| | Liver | 2 | 2019 | 1943 | 0.100 |
Why?
| | Eukaryota | 1 | 2013 | 57 | 0.100 |
Why?
| | Energy Metabolism | 2 | 2018 | 922 | 0.100 |
Why?
| | Bone Marrow Cells | 1 | 2014 | 316 | 0.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 220 | 0.100 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2014 | 199 | 0.090 |
Why?
| | Mitochondria | 2 | 2017 | 948 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2018 | 630 | 0.090 |
Why?
| | Genome, Human | 1 | 2014 | 425 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 596 | 0.090 |
Why?
| | Evolution, Molecular | 2 | 2018 | 493 | 0.090 |
Why?
| | Adipose Tissue | 1 | 2015 | 635 | 0.090 |
Why?
| | Mice, Transgenic | 3 | 2021 | 2167 | 0.090 |
Why?
| | Protein Footprinting | 1 | 2010 | 11 | 0.080 |
Why?
| | AT Rich Sequence | 1 | 2010 | 4 | 0.080 |
Why?
| | HIV-1 | 1 | 2016 | 864 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2017 | 1502 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2015 | 1457 | 0.080 |
Why?
| | Protein Structure, Tertiary | 3 | 2006 | 861 | 0.080 |
Why?
| | DNA Methylation | 1 | 2014 | 643 | 0.080 |
Why?
| | Inflammation | 1 | 2019 | 2837 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2025 | 3715 | 0.070 |
Why?
| | Nucleotide Motifs | 2 | 2020 | 35 | 0.070 |
Why?
| | DNA Primers | 2 | 2016 | 515 | 0.070 |
Why?
| | Amino Acids | 1 | 2010 | 497 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1590 | 0.060 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 59 | 0.060 |
Why?
| | Plasmodium falciparum | 1 | 2005 | 30 | 0.060 |
Why?
| | Malaria, Falciparum | 1 | 2005 | 27 | 0.060 |
Why?
| | Amino Acid Motifs | 1 | 2006 | 225 | 0.060 |
Why?
| | Peptide Chain Termination, Translational | 1 | 2025 | 9 | 0.060 |
Why?
| | Codon, Terminator | 1 | 2025 | 25 | 0.060 |
Why?
| | Sciuridae | 2 | 2018 | 147 | 0.060 |
Why?
| | Protozoan Proteins | 1 | 2005 | 82 | 0.060 |
Why?
| | Forkhead Box Protein O1 | 1 | 2025 | 33 | 0.060 |
Why?
| | Toll-Like Receptors | 1 | 2006 | 185 | 0.060 |
Why?
| | Metabolomics | 1 | 2010 | 678 | 0.060 |
Why?
| | Algorithms | 2 | 2010 | 1704 | 0.060 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2025 | 130 | 0.060 |
Why?
| | Models, Biological | 2 | 2015 | 1783 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2006 | 341 | 0.050 |
Why?
| | Databases, Nucleic Acid | 1 | 2004 | 34 | 0.050 |
Why?
| | Reverse Transcription | 2 | 2016 | 20 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2022 | 1396 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2004 | 93 | 0.050 |
Why?
| | Thiamine Pyrophosphate | 1 | 2002 | 3 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2006 | 430 | 0.050 |
Why?
| | Cobamides | 1 | 2002 | 20 | 0.050 |
Why?
| | Feedback, Physiological | 1 | 2002 | 77 | 0.050 |
Why?
| | Listeria monocytogenes | 1 | 2023 | 126 | 0.050 |
Why?
| | Phylogeny | 1 | 2006 | 904 | 0.050 |
Why?
| | Biological Evolution | 1 | 2006 | 474 | 0.050 |
Why?
| | Alphavirus | 1 | 2021 | 21 | 0.050 |
Why?
| | Kupffer Cells | 1 | 2021 | 50 | 0.050 |
Why?
| | Immunization | 1 | 2024 | 411 | 0.040 |
Why?
| | Phosphorothioate Oligonucleotides | 1 | 2021 | 11 | 0.040 |
Why?
| | Caveolae | 1 | 2021 | 18 | 0.040 |
Why?
| | Peptide Fragments | 2 | 2021 | 706 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 2021 | 112 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 298 | 0.040 |
Why?
| | Metadata | 1 | 2021 | 14 | 0.040 |
Why?
| | Ovalbumin | 1 | 2021 | 183 | 0.040 |
Why?
| | Female | 7 | 2025 | 73304 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 195 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2021 | 332 | 0.040 |
Why?
| | Epithelial Cells | 2 | 2014 | 1096 | 0.040 |
Why?
| | Embryoid Bodies | 1 | 2020 | 8 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 186 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 976 | 0.040 |
Why?
| | Endocytosis | 1 | 2021 | 172 | 0.040 |
Why?
| | Colony-Forming Units Assay | 1 | 2020 | 91 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2021 | 218 | 0.040 |
Why?
| | Molecular Conformation | 1 | 2000 | 145 | 0.040 |
Why?
| | Male | 6 | 2025 | 67762 | 0.040 |
Why?
| | Tricarboxylic Acids | 1 | 2018 | 10 | 0.040 |
Why?
| | beta-Defensins | 1 | 1998 | 21 | 0.040 |
Why?
| | Ketoglutaric Acids | 1 | 2018 | 16 | 0.040 |
Why?
| | Antibodies | 1 | 2001 | 410 | 0.040 |
Why?
| | Protein Structure, Secondary | 1 | 2000 | 374 | 0.040 |
Why?
| | Mesoderm | 1 | 2020 | 144 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 127 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2019 | 116 | 0.040 |
Why?
| | Electron Transport Complex II | 1 | 2018 | 26 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2025 | 803 | 0.040 |
Why?
| | Succinate Dehydrogenase | 1 | 2018 | 50 | 0.040 |
Why?
| | Early Growth Response Protein 2 | 1 | 2018 | 10 | 0.040 |
Why?
| | Lymphatic Vessels | 1 | 2019 | 64 | 0.040 |
Why?
| | Torpor | 1 | 2018 | 14 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 171 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2020 | 466 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2000 | 1092 | 0.040 |
Why?
| | NFATC Transcription Factors | 1 | 2018 | 95 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2017 | 46 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2021 | 483 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2018 | 193 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 674 | 0.030 |
Why?
| | G1 Phase | 1 | 2017 | 71 | 0.030 |
Why?
| | S Phase | 1 | 2017 | 77 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 233 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2017 | 124 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2017 | 145 | 0.030 |
Why?
| | Fibrosis | 1 | 2019 | 552 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 7635 | 0.030 |
Why?
| | Hematopoietic Stem Cells | 1 | 2020 | 406 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 1009 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 686 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 137 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1272 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 886 | 0.030 |
Why?
| | Uracil-DNA Glycosidase | 1 | 2015 | 1 | 0.030 |
Why?
| | GC Rich Sequence | 1 | 2015 | 4 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 132 | 0.030 |
Why?
| | Dyskinesias | 1 | 2015 | 19 | 0.030 |
Why?
| | Cell Respiration | 1 | 2015 | 103 | 0.030 |
Why?
| | DNA, Fungal | 1 | 2015 | 80 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 99 | 0.030 |
Why?
| | Electron Transport | 1 | 2015 | 115 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 108 | 0.030 |
Why?
| | Hydrolysis | 1 | 2014 | 177 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 622 | 0.030 |
Why?
| | Larva | 1 | 2015 | 226 | 0.030 |
Why?
| | Serrate-Jagged Proteins | 1 | 2014 | 27 | 0.030 |
Why?
| | Jagged-1 Protein | 1 | 2014 | 23 | 0.030 |
Why?
| | Argonaute Proteins | 1 | 2014 | 27 | 0.030 |
Why?
| | Receptors, Steroid | 1 | 2014 | 50 | 0.030 |
Why?
| | Wnt-5a Protein | 1 | 2014 | 23 | 0.030 |
Why?
| | Arousal | 1 | 2015 | 155 | 0.030 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.030 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2014 | 56 | 0.030 |
Why?
| | Body Temperature | 1 | 2015 | 222 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 327 | 0.030 |
Why?
| | Muscles | 1 | 2015 | 326 | 0.030 |
Why?
| | Stromal Cells | 1 | 2014 | 112 | 0.030 |
Why?
| | Chromatin | 1 | 2017 | 519 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2014 | 84 | 0.030 |
Why?
| | Poliovirus | 1 | 2014 | 85 | 0.030 |
Why?
| | RNA, Ribosomal | 1 | 2014 | 168 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2014 | 307 | 0.030 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2013 | 24 | 0.030 |
Why?
| | Wnt Proteins | 1 | 2014 | 133 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1793 | 0.020 |
Why?
| | Child | 2 | 2025 | 21935 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2014 | 218 | 0.020 |
Why?
| | Base Pairing | 2 | 2004 | 64 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 469 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 382 | 0.020 |
Why?
| | HeLa Cells | 1 | 2014 | 636 | 0.020 |
Why?
| | Hepacivirus | 1 | 2014 | 261 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 305 | 0.020 |
Why?
| | Virus Replication | 1 | 2014 | 483 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2189 | 0.020 |
Why?
| | Down-Regulation | 1 | 2014 | 657 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2014 | 436 | 0.020 |
Why?
| | Estrogens | 1 | 2014 | 367 | 0.020 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 306 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 545 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 648 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 860 | 0.020 |
Why?
| | Transcription Initiation Site | 1 | 2010 | 43 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2014 | 771 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5647 | 0.020 |
Why?
| | Time Factors | 1 | 2021 | 6828 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2010 | 117 | 0.020 |
Why?
| | Myocardium | 1 | 2015 | 1002 | 0.020 |
Why?
| | Adult | 2 | 2025 | 37929 | 0.020 |
Why?
| | Aged | 2 | 2019 | 23961 | 0.020 |
Why?
| | Organophosphates | 1 | 2010 | 134 | 0.020 |
Why?
| | Arabidopsis | 1 | 2010 | 95 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2010 | 534 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 391 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4295 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4149 | 0.020 |
Why?
| | Bayes Theorem | 1 | 2010 | 405 | 0.020 |
Why?
| | Genome | 1 | 2010 | 300 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2014 | 1164 | 0.020 |
Why?
| | Lung | 1 | 2019 | 4060 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3412 | 0.020 |
Why?
| | Chaperonin 60 | 1 | 2006 | 14 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2828 | 0.020 |
Why?
| | Aptamers, Nucleotide | 1 | 2006 | 83 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 21513 | 0.010 |
Why?
| | Prognosis | 1 | 2014 | 4030 | 0.010 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2006 | 99 | 0.010 |
Why?
| | Genetic Variation | 1 | 2010 | 991 | 0.010 |
Why?
| | Virulence Factors | 1 | 2005 | 167 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6079 | 0.010 |
Why?
| | Biotinylation | 1 | 2002 | 32 | 0.010 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2002 | 13 | 0.010 |
Why?
| | Automation | 1 | 2002 | 95 | 0.010 |
Why?
| | HIV Infections | 1 | 2016 | 2836 | 0.010 |
Why?
| | Directed Molecular Evolution | 1 | 2001 | 21 | 0.010 |
Why?
| | Infant | 1 | 2015 | 9465 | 0.010 |
Why?
| | Defensins | 1 | 1998 | 4 | 0.010 |
Why?
| | Internet | 1 | 2004 | 655 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2007 | 3284 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1998 | 316 | 0.010 |
Why?
| | Respiratory System | 1 | 1998 | 157 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 33479 | 0.010 |
Why?
| | Models, Molecular | 1 | 2001 | 1570 | 0.010 |
Why?
| | Interleukin-1 | 1 | 1998 | 965 | 0.010 |
Why?
|
|
Hesselberth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|